a public good project by the
Synthesis
Company
of California

© 2026

Mark Krailo | doi.page

0 works0 citations0 h-index

Mark Krailo

Publications by Year

Research Areas

Sarcoma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Testicular diseases and treatments, Cancer therapeutics and mechanisms, Lymphoma Diagnosis and Treatment

Most-Cited Works

→ Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone(2003)1,320 cited
→ Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group(2012)739 cited
→ Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group(2008)738 cited
→ Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate(2005)712 cited
→ Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort(2019)709 cited
→ ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer(1983)708 cited

→ The Role of Adjuvant Chemotherapy Following Cystectomy for Invasive Bladder Cancer: A Prospective Comparative Trial(1991)533 cited

→ Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial(2016)517 cited

→ Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.(1997)468 cited

→ Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration(2016)428 cited